Services
FNO Stocks with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
Equity Investment with CA Abhay
Stock Market Masterclass
Hamps Bio IPO: Allotment Finalised, Listing Tomorrow; GMP how to check allotment status
Team Finance Saathi
19/Dec/2024
What's covered under the Article:
- Detailed Hamps Bio IPO overview, including price band and market capitalization.
- Live updates on Hamps Bio IPO subscription status and GMP trends.
- Insights into Hamps Bio’s financial performance and the IPO’s market potential.
The Hamps Bio IPO offers an exciting opportunity for investors looking to explore the pharmaceutical and FMCG sectors. This Fixed Price Issue, amounting to ₹6.22 Crores, consists entirely of a fresh issue of 12.20 Lakh shares. The Hamps Bio IPO opens for subscription on December 13, 2024, and will close on December 17, 2024, with shares expected to be listed on the BSE SME on December 20, 2024.
The IPO price is set at ₹51 per equity share, which values the company at a market capitalization of ₹22.21 Crores at the issue price. With a lot size of 2,000 shares, retail investors will need to invest a minimum of ₹1,02,000. The IPO also caters to High-Net-Worth Individuals (HNIs) with a minimum investment of ₹2,04,000 (for 2 lots).
Grey Market Premium (GMP) for the Hamps Bio IPO is showing significant potential, with current trends indicating a premium of ₹43, suggesting 84.31% listing gains. However, as with any IPO, the market dynamics, demand-supply factors, and investor sentiments play a significant role in determining the final listing price. It's important to note that trading in the Grey Market is speculative and not recommended for making investment decisions.
Subscription Details:
The IPO subscription status as of December 17, 2024, reveals an overwhelming response, with the issue subscribed 1003.34 times by the third day of the subscription period. This is a clear indicator of the strong demand for the IPO, reflecting the confidence of investors in Hamps Bio’s growth potential. Investors can track the live subscription status through the official website.
Company Background:
Hamps Bio specializes in ethical marketing and distribution across a diverse range of pharmaceutical formulations and FMCG products, such as freeze-dried and frozen fruits, vegetables, herbs, and flowers. Their brand is well-recognized in both the pharmaceutical and FMCG segments. The company’s financials have shown a consistent upward trajectory, with a revenue of ₹436.42 Lakh for the period ending October 31, 2024. Over the past few years, Hamps Bio’s profitability has steadily increased, with profit after tax (PAT) touching ₹34.08 Lakh for FY24.
The company’s P/E ratio for the IPO is 28.98 pre-issue and 44.37 post-issue, indicating that the issue is priced in line with its growth and profitability. With an ROCE of 18.31% and an ROE of 21.14%, Hamps Bio’s financial health suggests a promising investment opportunity. However, potential investors must weigh the risks associated with smaller IPOs, especially those listed on the BSE SME platform.
Objective of the IPO:
The proceeds from the IPO will be utilized for purchasing plant and machinery for the FMCG division (₹359.00 Lakh), enhancing brand visibility (₹50.00 Lakh), and general corporate purposes (₹151.87 Lakh). These funds will support the company’s growth strategies, enabling it to scale operations and enhance its presence in the market.
Investment Consideration:
While the Hamps Bio IPO offers an exciting opportunity, investors should evaluate the financial performance, IPO pricing, and market conditions before applying. The strong demand indicated by the subscription figures and GMP trends make it an attractive option for those seeking listing gains. However, since this is a fixed-price issue, the potential for price movement post-listing is a critical factor to consider.
Investors looking for a detailed analysis of Hamps Bio’s IPO should refer to the latest IPO updates and market insights available. For those considering IPO investments, it’s always a good idea to stay informed with the latest trends and advice from trusted sources.
The Upcoming IPOs in this week and coming weeks are Ventive Hospitality, Senores Pharmaceuticals, Carraro India, Solar91 Cleantech, Unimech Aerospace, Rosmerta Digital, Indo Farm, and Avanse Financial.
The Current active IPO is Transrail Lighting, Mamata Machinery, DAM Capital Sanathan Textiles, Concord Enviro, Newmalayan Steel, Identical Brain Studios and NACDAC Infrastructure.